
|Articles|July 16, 2019
OmniComm Systems to be Acquired by Anju Software
Advertisement
OmniComm Systems, Inc. has announced that it has entered into a merger agreement with Anju Software, Inc., under which OmniComm will become a wholly owned subsidiary of Anju. The closing is expected to occur by October 31, 2019 following the satisfaction of customary closing conditions.
Find more details of the aquisition, right
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
2
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
3
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
4
Reducing Site Burden Through Better Technology Integration in Clinical Trials
5






.png)



.png)



.png)
.png)
